This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Philip Morris (PM) Benefits From IQOS Growth & Strong Pricing
by Zacks Equity Research
Philip Morris (PM) gains from growth in the RRPs category, backed by rising popularity of IQOS devices. Additionally, pricing power, especially for combustible products, is an upside.
Altria (MO) Sees Growth in Low-Risk Products, Pricing Aids
by Zacks Equity Research
Altria's (MO) low-risk tobacco offerings such as IQOS and on! are gaining popularity. Moreover, high pricing for tobacco products are an upside..
Top Analyst Reports for Exxon Mobil, AbbVie & Citigroup
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), AbbVie Inc. (ABBV), and Citigroup Inc. (C).
Altria (MO) Q1 Earnings Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
Altria's (MO) first-quarter performance is hurt by soft cigarette shipment volumes. Nevertheless, higher pricing continue to remain an upside.
Altria (MO) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of 2.88% and -2.20%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: NVIDIA, Booking Holdings, Altria Group, Moderna and Phillips 66
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NVIDIA, Booking Holdings, Altria Group, Moderna and Phillips 66
Top Analyst Reports for NVIDIA, Booking Holdings & Altria
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA (NVDA), Booking Holdings (BKNG), and Altria Group (MO).
Factors to Know Ahead of Altria's (MO) Q1 Earnings Release
by Zacks Equity Research
Altria's (MO) first-quarter performance is likely to have been affected by headwinds in cigarette and wine categories.
Earnings Preview: Altria (MO) Q1 Earnings Expected to Decline
by Zacks Equity Research
Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria (MO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $47.58 in the latest trading session, marking a +0.83% move from the prior day.
Altria (MO) Looks Steady on Low-Risk Products & Strong Pricing
by Zacks Equity Research
Altria (MO) gains from the popularity of low-risk tobacco alternatives such as IQOS. Moreover, strong pricing for tobacco products supports revenues.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $51.17, moving -1.12% from the previous trading session.
PepsiCo (PEP) to Report Q1 Earnings: Is a Beat in Store?
by Zacks Equity Research
Resilience in the snacks and foods business and accelerated growth in the beverage category are expected to have aided PepsiCo's (PEP) Q4 performance.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $51.13, moving -0.49% from the previous trading session.
Here's How Constellation Brands (STZ) Looks Before Q4 Earnings
by Zacks Equity Research
The strength of its brands and endeavors to adapt to the changes in the market is likely to have aided Constellation Brands (STZ) in Q4. Canopy-related headwinds are likely to have persisted.
Conagra (CAG) Queued for Q3 Earnings: Key Things to Note
by Zacks Equity Research
Conagra's (CAG) third-quarter fiscal 2021 results are likely to reflect strength in retail business driven by solid pandemic-induced demand. However, softness in Foodservice demand is a concern.
Philip Morris (PM) Gains on RRPs Popularity & Pricing Power
by Zacks Equity Research
Philip Morris' (PM) IQOS devices are gaining traction among consumers. Moreover, pricing power, especially for combustible products, is an upside.
Altria (MO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $51.26, moving -1.99% from the previous trading session.
Altria (MO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $49.51, moving -1.98% from the previous trading session.
Altria (MO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Altria (MO) closed at $49.78 in the latest trading session, marking a +0.69% move from the prior day.
Altria (MO) Benefits From Low-Risk Products & Pricing Power
by Zacks Equity Research
Altria (MO) gains from expansion of IQOS and oral tobacco offerings such as on! Moreover, pricing power is aiding revenues.
Altria (MO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Altria (MO) closed at $47.80, marking a -0.83% move from the previous day.
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Oracle, BHP, Starbucks and Altria Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Oracle, BHP, Starbucks and Altria Group
Top Stock Reports for Berkshire Hathaway, Oracle & BHP
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Oracle (ORCL), and BHP Group (BHP).
Altria (MO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Altria (MO) closed the most recent trading day at $45.12, moving +1.94% from the previous trading session.